Company
Headquarters: Quincy, FL, United States
Employees: 6,900
CEO: Ms. Kimberly Rivers
$1.66 Billion
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, West Virginia, Arizona, and Maryland, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under Cultivar Collection, Momenta, Muse, Sweet Talk, Alchemy, Avenue, Co2lors, Loveli, Modern Flower, and Roll One brands. As of February 10, 2022, the company operated 161 dispensaries, including 112 dispensaries in Florida. Trulieve Cannabis Corp. has a strategic partnership with SLANG Worldwide Inc. to supply branded cannabis products in Massachusetts. The company is headquartered in Quincy, Florida.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $1.17 B |
| EBITDA | $300.5 M |
| Gross Profit TTM | $682.6 M |
| Profit Margin | -10.98% |
| Operating Margin | -1.29% |
| Quarterly Revenue Growth | 3.30% |
Trulieve Cannabis Corp has the following listings and related stock indices.
Stock: OTC: TCNNF
Stock: CSE: TRUL
Stock: FSX: T0A